drugset / Trial / NCT03665753

Comparison of IV 10, 20, and 30mg for Renal Colic Pain in the ED

NCT03665753

Phase 0 Completed 165 enrolled Tehran University of Medical Sciences
RandomizedSequentialQuadruple-blindTreatment

Summary

Hypothesis: Intravenous administration of Ketorolac 10 mg and 20 mg is as effective as 30 mg in treating renal colic pain in patients presenting to the emergency department

Timeline

Start
2018-11-05
Primary completion
2019-09-09
Completion
2019-11-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 10 mg Intravenous
Subject Ketorolac Other / unclassified 20 mg Intravenous
Subject Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.